
    
      This is a randomized, double-blind, placebo-controlled scintigraphy study to investigate the
      effect of oral CIN-102 on gastric emptying and antral contractility in adults with diabetic
      gastroparesis. The population for this study is adult patients 18 to 70 years old with Type 1
      or Type 2 diabetes and a diagnosis of diabetic gastroparesis. The study will consist of two
      cohorts with approximately 15 subjects in each cohort.
    
  